Description
Indications
Basic therapy for various forms of bronchial asthma in adults and children 4 years of age and older.
Maintenance therapy for chronic obstructive pulmonary disease (COPD) in patients with forced expiratory volume (FEV1) < 50% of the proper values (after inhalation of the bronchodilator) and repeated exacerbations in the anamnesis, in which severe symptoms of the disease persist, despite regular therapy with bronchodilators. Contraindications Age up to 4 years. Hypersensitivity to any component of the drug. Beclomethasone aeronativ should be used with caution in case of glaucoma, systemic infections (bacterial, viral, fungal, parasitic), osteoporosis, pulmonary tuberculosis, cirrhosis, hypothyroidism, pregnancy, and lactation. Use during pregnancy and lactation During pregnancy and during breastfeeding, beclomethasone aeronativ can be prescribed only if the intended benefit to the mother outweighs any possible risk to the fetus or baby. Special instructions Beclomethasone is not intended for the relief of acute asthmatic attacks. It should also not be used for severe asthma attacks requiring intensive care. The recommended route of administration for the dosage form used should be strictly observed. With extreme caution and under the close supervision of a physician, beclomethasone should be used in patients with adrenal insufficiency. Transfer of patients, constantly taking corticosteroids inside, for inhalation forms can be made only with a stable condition. In the case of the likelihood of developing paradoxical bronchospasm 10-15 minutes before the administration of beclomethasone, bronchodilators (e.g., salbutamol) are inhaled. With the development of candidiasis of the oral cavity and upper respiratory tract, local antifungal therapy is indicated without stopping beclomethasone treatment. Infectious and inflammatory diseases of the nasal cavity and paranasal sinuses when prescribing appropriate therapy are not a contraindication for the treatment of beclomethasone. Inhalation preparations containing 250 μg beclomethasone in 1 dose are not intended for children under 12 years of age. Composition 1 dose contains beclomethasone 250 mcg. Dosage and administration of The drug “beclomethasone-aeronativ” is intended only for inhalation administration. Bronchial asthma Adults and children 12 years of age and older: beclomethasone aeronativ is used regularly (even in the absence of disease symptoms), the dose of beclomethasone dipropionate is selected taking into account the severity of bronchial asthma and the clinical effect in each case. The daily dose is divided into several doses. Recommended starting doses: mild bronchial asthma – 200 – 600 mcg / day mild bronchial asthma – 600 – 1000 mcg / day severe asthma – 1000 – 2000 mcg / day Children aged 4 to 12 years: Up to 400 mcg per day in several doses Depending on the individual response of the patient, the dose of the drug can be increased until the clinical effect appears or reduced to the minimum effective dose. When switching to a high dose of inhaled beclomethasone dipropionate, many patients receiving systemic glucocorticosteroids will be able to reduce their dose or cancel them altogether. Chronic obstructive pulmonary disease The maximum recommended dose of beclomethasone-aeronativ with COPD is 2000 mcg per day. If you accidentally skip inhalation, the next dose must be taken at the right time in accordance with the treatment regimen. Introduction can be carried out using special dispensers (spacers) that improve the distribution of the drug in the lungs and reduce the risk of side effects. Patients with impaired liver function In patients with impaired liver function, a dose reduction is not required. Patients with impaired renal function In patients with impaired renal function, a dose reduction is not required. Side effects Frequency determination: very often (> 1/10), often (1/100 to 1/10), infrequently (1/1000 to 1/100), rarely (1/10000 to 1 / 000), very rarely (<1/10000). From the side of metabolism: rarely – hypercorticism is very rare – symptoms of systemic glucocorticosteroid effects (including adrenal hypofunction, Cushing’s syndrome). From the side of the immune system: rarely – hypersensitivity reactions, rash, urticaria, angioedema, itching. From the musculoskeletal system: a decrease in bone mineral density. From the respiratory system: often – cough rarely – paradoxical bronchospasm, pharyngeal irritation, dysphonia, disappearing after discontinuation of therapy or dose reduction. Other: often – candidiasis of the mucous membrane of the oral cavity and larynx. The systemic effect of inhaled corticosteroids can be observed when taking the drug in high doses for a long time. Overdose of An acute overdose of the drug can lead to a temporary decrease in the function of the adrenal cortex, which does not require emergency therapy, since the function of the adrenal cortex is restored within a few days, which is confirmed by the level of plasma cortisol. In chronic overdose, persistent suppression of adrenal cortex function may be noted. In such cases, it is recommended to monitor the reserve function of the adrenal cortex. In case of an overdose, beclomethasone dipropionate treatment can be continued in doses sufficient to maintain a therapeutic effect. To avoid overdose, patients should not use beclomethasone-aeronativ in doses exceeding the recommended ones. Of great importance is the regular assessment of the effectiveness of therapy and a reduction in the dose of beclomethasone-aeronativ to a minimum level that provides effective control of the symptoms of the disease. Storage conditions In a dark place at a temperature of no higher than 25 ° C, away from heaters. Do not freeze. Keep out of the reach of children. Expiration 2 years. Deystvuyuschee substances beclomethasone pharmacy terms and conditions prescription Form of Treatment aÑrozoly dlya ingalyatsiy Appointment Adult prescription, Prescribing children Indications Chronic obstructive pulmonary disease, Bronchial asthma Possible product names Becklomethasone-Aeronative aerosol for inhalation 100 mcg / dose, 200 mg aerosol 250 dose 80gf / dose, 200 doses
